Federal appeals court says Teva must delist Orange Book inhaler patentsnews2024-12-23T19:08:01+00:00December 23rd, 2024|Endpoints News|
CMS explains what went into its first round of drug price negotiationsnews2024-12-23T18:55:19+00:00December 23rd, 2024|Endpoints News|
Drugmakers sue government over 340B discounts to STD clinicsnews2024-12-23T18:41:47+00:00December 23rd, 2024|Endpoints News|
Novartis, AbbVie and PhRMA secure 340B court win in West Virginianews2024-12-18T19:44:19+00:00December 18th, 2024|Endpoints News|
Major PBM reforms feature in Congress’ year-end spending billnews2024-12-17T20:26:20+00:00December 17th, 2024|Endpoints News|
Sandoz agrees to $275M settlement in generic antitrust litigationnews2024-12-17T20:14:37+00:00December 17th, 2024|Endpoints News|
Employee lawsuit over J&J’s own health costs may loosen PBMs’ gripnews2024-12-17T14:30:14+00:00December 17th, 2024|Endpoints News|
McKinsey fined $650M for deceiving US on opioid consultingnews2024-12-13T20:40:09+00:00December 13th, 2024|Endpoints News|
FDA stands by mifepristone safety label in federal court challengenews2024-12-13T20:03:13+00:00December 13th, 2024|Endpoints News|
Padlock shareholders sue Bristol Myers over milestone dispute after 2016 acquisitionnews2024-12-12T16:20:04+00:00December 12th, 2024|Endpoints News|
